目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global multiple myeloma drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global multiple myeloma drugs market 2017 - 2021 ($ million)
4.2 Therapy Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapy
6.1 Market segments
Exhibit 30: Chart on Therapy - Market share 2022-2027 (%)
Exhibit 31: Data Table on Therapy - Market share 2022-2027 (%)
6.2 Comparison by Therapy
Exhibit 32: Chart on Comparison by Therapy
Exhibit 33: Data Table on Comparison by Therapy
6.3 Targeted therapy - Market size and forecast 2022-2027
Exhibit 34: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
6.4 Biologic therapy - Market size and forecast 2022-2027
Exhibit 38: Chart on Biologic therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Biologic therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Biologic therapy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Biologic therapy - Year-over-year growth 2022-2027 (%)
6.5 Chemotherapy - Market size and forecast 2022-2027
Exhibit 42: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Therapy
Exhibit 50: Market opportunity by Therapy ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 51: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 52: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 53: Chart on Comparison by Distribution Channel
Exhibit 54: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 55: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
7.4 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 59: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
7.5 E-pharmacy - Market size and forecast 2022-2027
Exhibit 63: Chart on E-pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on E-pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on E-pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on E-pharmacy - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 67: Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 71: Chart on Geographic comparison
Exhibit 72: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 105: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 109: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 112: Overview on factors of disruption
11.4 Industry risks
Exhibit 113: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 114: Vendors covered
12.2 Market positioning of vendors
Exhibit 115: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 116: Abbott Laboratories - Overview
Exhibit 117: Abbott Laboratories - Business segments
Exhibit 118: Abbott Laboratories - Key news
Exhibit 119: Abbott Laboratories - Key offerings
Exhibit 120: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 121: AbbVie Inc. - Overview
Exhibit 122: AbbVie Inc. - Product / Service
Exhibit 123: AbbVie Inc. - Key offerings
12.5 Amgen Inc.
Exhibit 124: Amgen Inc. - Overview
Exhibit 125: Amgen Inc. - Product / Service
Exhibit 126: Amgen Inc. - Key offerings
12.6 Bristol Myers Squibb Co.
Exhibit 127: Bristol Myers Squibb Co. - Overview
Exhibit 128: Bristol Myers Squibb Co. - Product / Service
Exhibit 129: Bristol Myers Squibb Co. - Key offerings
12.7 Daiichi Sankyo Co. Ltd.
Exhibit 130: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 131: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 132: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 134: Daiichi Sankyo Co. Ltd. - Segment focus
12.8 F. Hoffmann La Roche Ltd.
Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
Exhibit 140: GlaxoSmithKline Plc - Overview
Exhibit 141: GlaxoSmithKline Plc - Business segments
Exhibit 142: GlaxoSmithKline Plc - Key offerings
Exhibit 143: GlaxoSmithKline Plc - Segment focus
12.10 Johnson and Johnson
Exhibit 144: Johnson and Johnson - Overview
Exhibit 145: Johnson and Johnson - Business segments
Exhibit 146: Johnson and Johnson - Key news
Exhibit 147: Johnson and Johnson - Key offerings
Exhibit 148: Johnson and Johnson - Segment focus
12.11 Merck and Co. Inc.
Exhibit 149: Merck and Co. Inc. - Overview
Exhibit 150: Merck and Co. Inc. - Business segments
Exhibit 151: Merck and Co. Inc. - Key news
Exhibit 152: Merck and Co. Inc. - Key offerings
Exhibit 153: Merck and Co. Inc. - Segment focus
12.12 Novartis AG
Exhibit 154: Novartis AG - Overview
Exhibit 155: Novartis AG - Business segments
Exhibit 156: Novartis AG - Key offerings
Exhibit 157: Novartis AG - Segment focus
12.13 Pfizer Inc.
Exhibit 158: Pfizer Inc. - Overview
Exhibit 159: Pfizer Inc. - Product / Service
Exhibit 160: Pfizer Inc. - Key news
Exhibit 161: Pfizer Inc. - Key offerings
12.14 PharmaMar SA
Exhibit 162: PharmaMar SA - Overview
Exhibit 163: PharmaMar SA - Business segments
Exhibit 164: PharmaMar SA - Key news
Exhibit 165: PharmaMar SA - Key offerings
Exhibit 166: PharmaMar SA - Segment focus
12.15 Sanofi SA
Exhibit 167: Sanofi SA - Overview
Exhibit 168: Sanofi SA - Business segments
Exhibit 169: Sanofi SA - Key news
Exhibit 170: Sanofi SA - Key offerings
Exhibit 171: Sanofi SA - Segment focus
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 174: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 175: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 176: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 177: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 178: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 179: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 180: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 181: Inclusions checklist
Exhibit 182: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 183: Currency conversion rates for US$
13.4 Research methodology
Exhibit 184: Research methodology
Exhibit 185: Validation techniques employed for market sizing
Exhibit 186: Information sources
13.5 List of abbreviations
Exhibit 187: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global multiple myeloma drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Therapy - Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy
Exhibits33: Data Table on Comparison by Therapy
Exhibits34: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Biologic therapy - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Biologic therapy - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Biologic therapy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Biologic therapy - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Therapy ($ million)
Exhibits51: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits52: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by Distribution Channel
Exhibits54: Data Table on Comparison by Distribution Channel
Exhibits55: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on E-pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on E-pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on E-pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on E-pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Distribution Channel ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Abbott Laboratories - Overview
Exhibits117: Abbott Laboratories - Business segments
Exhibits118: Abbott Laboratories - Key news
Exhibits119: Abbott Laboratories - Key offerings
Exhibits120: Abbott Laboratories - Segment focus
Exhibits121: AbbVie Inc. - Overview
Exhibits122: AbbVie Inc. - Product / Service
Exhibits123: AbbVie Inc. - Key offerings
Exhibits124: Amgen Inc. - Overview
Exhibits125: Amgen Inc. - Product / Service
Exhibits126: Amgen Inc. - Key offerings
Exhibits127: Bristol Myers Squibb Co. - Overview
Exhibits128: Bristol Myers Squibb Co. - Product / Service
Exhibits129: Bristol Myers Squibb Co. - Key offerings
Exhibits130: Daiichi Sankyo Co. Ltd. - Overview
Exhibits131: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits132: Daiichi Sankyo Co. Ltd. - Key news
Exhibits133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits134: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits135: F. Hoffmann La Roche Ltd. - Overview
Exhibits136: F. Hoffmann La Roche Ltd. - Business segments
Exhibits137: F. Hoffmann La Roche Ltd. - Key news
Exhibits138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits139: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits140: GlaxoSmithKline Plc - Overview
Exhibits141: GlaxoSmithKline Plc - Business segments
Exhibits142: GlaxoSmithKline Plc - Key offerings
Exhibits143: GlaxoSmithKline Plc - Segment focus
Exhibits144: Johnson and Johnson - Overview
Exhibits145: Johnson and Johnson - Business segments
Exhibits146: Johnson and Johnson - Key news
Exhibits147: Johnson and Johnson - Key offerings
Exhibits148: Johnson and Johnson - Segment focus
Exhibits149: Merck and Co. Inc. - Overview
Exhibits150: Merck and Co. Inc. - Business segments
Exhibits151: Merck and Co. Inc. - Key news
Exhibits152: Merck and Co. Inc. - Key offerings
Exhibits153: Merck and Co. Inc. - Segment focus
Exhibits154: Novartis AG - Overview
Exhibits155: Novartis AG - Business segments
Exhibits156: Novartis AG - Key offerings
Exhibits157: Novartis AG - Segment focus
Exhibits158: Pfizer Inc. - Overview
Exhibits159: Pfizer Inc. - Product / Service
Exhibits160: Pfizer Inc. - Key news
Exhibits161: Pfizer Inc. - Key offerings
Exhibits162: PharmaMar SA - Overview
Exhibits163: PharmaMar SA - Business segments
Exhibits164: PharmaMar SA - Key news
Exhibits165: PharmaMar SA - Key offerings
Exhibits166: PharmaMar SA - Segment focus
Exhibits167: Sanofi SA - Overview
Exhibits168: Sanofi SA - Business segments
Exhibits169: Sanofi SA - Key news
Exhibits170: Sanofi SA - Key offerings
Exhibits171: Sanofi SA - Segment focus
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits173: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits174: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits175: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits176: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits177: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits178: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits179: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits180: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits181: Inclusions checklist
Exhibits182: Exclusions checklist
Exhibits183: Currency conversion rates for US$
Exhibits184: Research methodology
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Information sources
Exhibits187: List of abbreviations